Reversal of islet atrophy and restoration of fas ligand expression by RXR and PPARγ activators in db/db mice

被引：0
|
作者：
Thomazy, VA
Crombie, DL
Heyman, RA
Davies, PJA
机构：
[1] Univ Texas, Sch Med, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Dept Integrat Biol, Houston, TX 77030 USA
[3] Ligand Pharmaceut Inc, San Diego, CA USA
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
395
引用
收藏
页码：70A / 70A
页数：1
相关论文
共 23 条
  • [21] Fas ligand (CD95L) expression in rejecting islet allografts in IL-2 knock out mice.
    Manfro, RC
    RoyChaudhury, P
    Zheng, XX
    Li, YS
    Tian, Y
    Strom, TB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3213 - A3213
  • [22] Fas ligand down-regulates cytokine-induced fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice
    Augstein, P
    Heinke, P
    Salzsieder, E
    Berg, S
    Rettig, R
    Salzsieder, C
    Harrison, LC
    ENDOCRINOLOGY, 2004, 145 (06) : 2747 - 2752
  • [23] The loss of GLUT2 expression in the beta-cells of diabetic db/db mice is associated with a decrease in binding affinity of an islet-specific trans-acting factor which control GLUT2 gene transcription.
    Bonny, C
    Roduit, R
    Thorens, B
    Nicod, P
    Waeber, G
    DIABETES, 1996, 45 : 70 - 70
123